Creation Of Human Embryonic Stem Cell Lines That Avoid Immune Rejection

In a groundbreaking experiment published in Cloning & Stem Cells, scientists from International Stem Cell (ISC) Corp. derived four unique embryonic stem cell lines that open the door for the creation of therapeutic cells that will not provoke an immune reaction in large segments of the population. The stem cell lines are “HLA-homozygous,” meaning that they have a simple genetic profile in the critical areas of the DNA that code for immune rejection. [click link for full article]

More: continued here

Filed under: Immune System / Vaccines on December 24th, 2007